Influence of Body Mass Index on Prognosis of Japanese Patients with Renal Cell Carcinoma

Urology

Volumn 70, Issue 1, 2007, Pages 50-54

  Awakura, Yasuo ^a   Nakamura, Eijiro ^a   Ito, Noriyuki ^a   Yamasaki, Toshinari ^a   Kamba, Tomomi ^a   Kamoto, Toshiyuki ^a   Ogawa, Osamu ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; JAPANESE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS;

BODY MASS INDEX; CARCINOMA, RENAL CELL; FEMALE; HUMANS; JAPAN; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 34447536150     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.03.034     Document Type: Article

References (19)

1. van Dijk B.A., Schouten L.J., Kiemeney L.A., et al. Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: results from the Netherlands Cohort Study. Am J Epidemiol 160 (2004) 1159-1167
2. Yu H., and Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92 (2000) 1472-1489
3. Sacchi M., Pincelli A.I., and Cavagnini F. Growth hormone in obesity. Int J Obes Relat Metab Disord 23 (1999) 260-271
4. Gago-dominguez M., Castelao J.E., Yuan J.M., et al. Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control 13 (2002) 287-293
5. Yoshiike N., Kaneda F., and Takimoto H. Epidemiology of obesity and public health strategies for its control in Japan. Asia Pac J Clin Nutr 11 suppl 8 (2002) S727-S731
6. Ajiki W., Tsukuma H., and Oshima A. Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol 34 (2004) 352-356
7. Bergstrom A., Pisani P., Tenet V., et al. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 91 (2001) 421-430
8. Haenszel W.M. Contributions of end results data to cancer epidemiology. Natl Cancer Inst Monogr 15 (1964) 21-33
9. Strom S.S., Wang X., Pettaway C.A., et al. Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. Clin Cancer Res 11 (2005) 6889-6894
10. Tao M.H., Shu X.O., Ruan Z.X., et al. Association of overweight with breast cancer survival. Am J Epidemiol 163 (2006) 101-107
11. Yu M.L., Asal N.R., and Geyer J.R. Later recurrence and longer survival among obese patients with renal cell carcinoma. Cancer 68 (1991) 1648-1655
12. Kamat A.M., Shock R.P., Naya Y., et al. Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors. Urology 63 (2004) 46-50
13. Rasmuson T., Grankvist K., Jacobsen J., et al. Serum insulin-like growth factor-1 is an independent predictor of prognosis in patients with renal cell carcinoma. Acta Oncol 43 (2004) 744-748
14. Schips L., Lipsky K., Zigeuner R., et al. Does overweight impact on the prognosis of patients with renal cell carcinoma?. A single center experience of 683 patients. J Surg Oncol 88 (2004) 57-62
15. Donat S.M., Salzhauer E.W., Mitra N., et al. Impact of body mass index on survival of patients with surgically treated renal cell carcinoma. J Urol 175 (2006) 46-52
16. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004) 157-163
17. Trayhurn P. Endocrine and signaling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 184 (2005) 285-293
18. La Cava A., Alviggi C., and Matarese G. Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med 82 (2004) 4-11
19. Onishi T., Ohishi Y., Goto H., et al. An assessment of the immunological status of patients with renal cell carcinoma based on the relative abundance of T-helper-1 and -2 cytokine-producing CD4+ cells in peripheral blood. BJU Int 87 (2001) 755-759